CAR T-Cell Trials Boast Promising Results – The Scientist
The Scientist |
CAR T-Cell Trials Boast Promising Results
The Scientist Multiple myeloma cellsWIKIMEDIA, KGHNanjing Legend Biotech's chimeric antigen receptor T–cell (CAR T) therapy induced some level of remission within two months in 33 of 35 multiple myeloma patients in an ongoing clinical trial, according to results … Blood and bone marrow therapies grab spotlight at world's top … Blood cancer treatment called 'revolutionary' after all study patients responded |
